Truv’s product team has been hard at work delivering new features in the month of April. With new product launches,...
Biogen Inc. is a multinational biopharmaceutical company with its headquarters in Cambridge, Massachusetts. The company specializes in the research, development, and marketing of treatments for neurological and neurodegenerative diseases, autoimmune disorders, and hemophilia. It was founded in 1978 by Charles Weissmann, Kenneth Murray, and Phillip Allen Sharp in Geneva, Switzerland. Biogen’s best-known drug is the multiple sclerosis (MS) treatment, Avonex. In addition to MS, Biogen has also developed treatments for other neurodegenerative diseases such as spinal muscular atrophy (SMA), amyotrophic lateral sclerosis (ALS), and Alzheimer’s disease. The company’s research and development efforts include gene therapy, gene editing, protein engineering, and gene silencing. With a strong focus on research and innovation, Biogen has established itself as a leading player in the biopharmaceutical industry. The company operates in over 90 countries worldwide and has a significant presence in the United States and Europe. As of 2021, Biogen employs over 7,000 people globally and has a market capitalization of over $50 billion.
The information on this page is not an endorsement of Truv’s services by Biogen and is meant to be purely informational.
Verify Biogen Employees
Truv allows you to complete employee, employment and income verifications faster. The process is simple and automated, and most employees are verified within 24 hours. Verifiers love Truv because it’s never been easier and more streamlined to verify an employee, learn more here.
Not the Employer You
were Looking for?
Not the Employer You were Looking for?
Learn more about verifications...
Product Update: February 2023
Truv’s product team has been hard at work delivering new features in the month of February. We are continuing our...
Mar 9, 2023